Betterment’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$202K Sell
1,064
-260
-20% -$44.7K ﹤0.01% 667
2026
Q1
$224K Buy
+1,324
New +$226K ﹤0.01% 585

Other funds holding IBB

Betterment's IBB Position: Q2 2026 in Review

Betterment reduced its iShares Biotechnology ETF (IBB) stake by 20% in Q2 2026, selling an estimated $44.7K and leaving 1,064 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #667.

Betterment first reported a position in IBB in Q1 2026 and has held it in 2 quarters since. The position peaked at $224K in Q1 2026. 963 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Betterment held 1,064 shares of iShares Biotechnology ETF worth $202K as of Q2 2026.
  • Betterment sold 260 iShares Biotechnology ETF shares in Q2 2026, an estimated $44.7K.
  • iShares Biotechnology ETF made up ﹤0.01% of Betterment's portfolio in Q2 2026, its #667 holding.
  • Betterment first reported a position in iShares Biotechnology ETF in Q1 2026 and has held it in 2 quarters since.
  • Betterment's iShares Biotechnology ETF position peaked at $224K in Q1 2026.
  • 963 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Betterment's 13F filing for Q2 2026, filed 14 Aug 2026.